Skip Navigation

Program Title: Managed Access Program MAP Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel CTL019; Kymriah�

Brief Summary

Type:
Other

Study Type:
Other

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT03601442

Study #:
STUDY00144517

Start Date:
Feb 13, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03601442

View Complete Trial Details & Eligibility at ClinicalTrials.gov